GLP-1 Research

New research confirms that 25–40% of weight lost on GLP-1 medications can come from lean mass — here's…

A comprehensive look at the latest clinical research on GLP-1 receptor agonists and liver fat reduction in MASLD…

New research shows GLP-1 medications can significantly reduce the risk of cirrhosis and liver-related mortality in men with…

Ozempic is a GLP-1 receptor agonist containing semaglutide — a synthetic gut hormone analog that suppresses appetite and…

A science-backed breakdown of the Ozempic dose increase schedule, explaining the clinical rationale behind each escalation step and…

Semaglutide can cause you to lose as much muscle as 20 years of aging in a single treatment…

GLP-1 receptor agonists are reshaping metabolic medicine — here is what the latest research reveals about how they…

A PubMed-backed breakdown of Ozempic's most common and rare side effects — from GI symptoms to gallbladder risk…

GLP-1 medications like semaglutide work by mimicking a gut hormone that regulates insulin, slows gastric emptying, and quiets…

Waist-to-hip ratio (WHR) is one of the most clinically validated body composition metrics for assessing metabolic risk —…